Literature DB >> 25333673

Resveratrol inhibits the proliferation of human melanoma cells by inducing G1/S cell cycle arrest and apoptosis.

Zhiyuan Wu1, Bin Liu1, Cailing E2, Jie Liu1, Qingyu Zhang1, Juntao Liu3, Nianping Chen4, Rongyi Chen2, Runzhi Zhu4.   

Abstract

Resveratrol (Res), a natural plant extract, is an effective inducer of cell apoptosis and cell cycle arrest in multiple carcinoma cell types, which has been demonstrated by its ability to inhibit the proliferation of multiple human tumor cells in vitro. Although Res possesses chemopreventive properties against several types of cancer, the molecular mechanism underlying its anticancer activity remains to be fully elucidated. The present study demonstrated that Res induced cell cycle arrest and inhibited the proliferation of human melanoma A375 (IC50=23 µM after 48 h; P<0.05) and SK-MEL-31 (IC50=15 µM after 48 h; P<0.05) cells. Western blot analysis demonstrated that Res induced the apoptosis of human melanoma A375 and SK-MEL-31 cells by upregulating the expression of Bcl-2-associated X protein and B-cell lymphoma 2, possibly via the p53 pathway and activation of caspase-9 and caspase-3.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25333673     DOI: 10.3892/mmr.2014.2716

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  15 in total

1.  Novel Curcumin-Resveratrol Solid Nanoparticles Synergistically Inhibit Proliferation of Melanoma Cells.

Authors:  Gayathri Heenatigala Palliyage; Noor Hussein; Michael Mimlitz; Catherine Weeder; Marya Hassan A Alnasser; Somnath Singh; Andrew Ekpenyong; Amit K Tiwari; Harsh Chauhan
Journal:  Pharm Res       Date:  2021-05-12       Impact factor: 4.200

2.  4'-Bromo-resveratrol, a dual Sirtuin-1 and Sirtuin-3 inhibitor, inhibits melanoma cell growth through mitochondrial metabolic reprogramming.

Authors:  Jasmine George; Minakshi Nihal; Chandra K Singh; Nihal Ahmad
Journal:  Mol Carcinog       Date:  2019-07-10       Impact factor: 4.784

Review 3.  Use of Polyphenolic Compounds in Dermatologic Oncology.

Authors:  Adilson Costa; Michael Yi Bonner; Jack L Arbiser
Journal:  Am J Clin Dermatol       Date:  2016-08       Impact factor: 7.403

Review 4.  Melanoma Chemoprevention: Current Status and Future Prospects.

Authors:  Gagan Chhabra; Mary Ann Ndiaye; Liz Mariely Garcia-Peterson; Nihal Ahmad
Journal:  Photochem Photobiol       Date:  2017-04-27       Impact factor: 3.421

5.  Pro-apoptotic and anti-proliferative effects of corn silk extract on human colon cancer cell lines.

Authors:  Hao Guo; Hong Guan; Wenqin Yang; Han Liu; Huiling Hou; Xue Chen; Zhenyan Liu; Chuangang Zang; Yuchao Liu; Jicheng Liu
Journal:  Oncol Lett       Date:  2016-12-05       Impact factor: 2.967

Review 6.  Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer.

Authors:  Saleh A Almatroodi; Mohammed A Alsahli; Abdullah S M Aljohani; Fahad A Alhumaydhi; Ali Yousif Babiker; Amjad Ali Khan; Arshad Husain Rahmani
Journal:  Molecules       Date:  2022-04-21       Impact factor: 4.927

7.  Resveratrol-induced apoptosis is associated with regulating the miR-492/CD147 pathway in malignant melanoma cells.

Authors:  Shuang Zhao; Ling Tang; Wangqing Chen; Juan Su; Fangfang Li; Xiang Chen; Lisha Wu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-03       Impact factor: 3.000

8.  Folic acid-functionalized drug delivery platform of resveratrol based on Pluronic 127/D-α-tocopheryl polyethylene glycol 1000 succinate mixed micelles.

Authors:  Jifu Hao; Tiantian Tong; Kai Jin; Qiannan Zhuang; Te Han; Yanping Bi; Jianzhu Wang; Xiaodan Wang
Journal:  Int J Nanomedicine       Date:  2017-03-24

Review 9.  Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio.

Authors:  Marike W van Gisbergen; Emma Zwilling; Ludwig J Dubois
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

10.  Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.

Authors:  Shu Yang; Wenshuai Li; Haimei Sun; Bo Wu; Fengqing Ji; Tingyi Sun; Huanhuan Chang; Ping Shen; Yaxi Wang; Deshan Zhou
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.